← Back to headlines
TG Therapeutics Secures $750M Credit Facility, Boosts Buyback to $300M
TG Therapeutics has successfully secured a $750 million credit facility with Blue Owl and simultaneously announced an increase in its share buyback program to $300 million.
19 Mar, 11:38 — 19 Mar, 11:38
Sources
Showing 1 of 1 sources
